Skip to main content
OpenTrials
Completed

NCT Number: NCT02456077

Strengthening Physician Communication About HPV Vaccines

The purpose of this study is to determine if a multimodal Human Papillomavirus (HPV) immunization program carried out in pediatric and family medicine practices would be more effective in improving adolescent patients' HPV immunization rates than the usual care provided to adolescents in pediatric and family medicine practices.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HPV Immunization Status

Age range

9 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Colorado Denver

Aurora, Colorado, 80045, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for immunization rate assessment:

  • 9 years of age or older when presenting for care
  • Patients who present for care one year prior to the start of the intervention and up to two years after the start of the intervention

Exclusion criteria

  • Less than 9 years of age when presenting for care
  • Patient is not eligible for HPV immunization

Provider survey:

Providers who are working at participating practices during the two times a cross-sectional survey is administered.

Parent survey:

Parents of adolescents who presented for care within one 1 year prior to the two times a cross-sectional survey is administration.

Treatment and study plan

Multimodal Vaccine Program

Behavioral

Efforts will be made to collaborate with pediatric and family medicine offices to utilize a multimodal intervention to improve adolescents' HPV immunization rates. As part of the overall intervention, four intervention strategies will be used: 1) a tailored website, iVac -HPV , 2) Motivational Interview Training for providers, 3) HPV Fact Sheets and 4) The Decision Aid for HPV Vaccines

Primary outcomes

  1. The percentage of adolescents who initiate the HPV vaccine series

    Time frame: 1 year

    The percent of eligible patients presenting for care at intervention offices who receive one or more HPV vaccines (using administrative, Electronic Medical Records (EMR), and Colorado Immunization Information System (CIIS) immunization data), during the intervention year, compared to the percent in control offices.

Secondary outcomes

  1. The percentage of adolescents who receive MCV4 vaccine

    Time frame: 1 year

    The percent of eligible patients presenting for care at intervention offices who receive MCV4 vaccine (using administrative, EMR and CIIS immunization data) compared to the percent in control offices.

  2. The percentage of adolescents who receive Tdap vaccine

    Time frame: 1 year

    The percentage of eligible patients presenting for care at intervention offices who receive Tetanus, Diphtheria, Pertussis (Tdap) vaccine (using administrative, EMR and CIIS immunization data) during the intervention year compared to the percent in control offices.

  3. Provider HPV vaccine recommendations

    Time frame: 1 year

    The change in intervention providers' HPV vaccine communication practices compared to control providers' as measured by self-report prior to the intervention and after the intervention.

  4. Parents' experiences and preferences regarding provider communication about HPV vaccines

    Time frame: 1 year

    The change in intervention parents' experiences and preferences regarding provider HPV vaccine communication compared to parents of adolescents attending control practices as measured by self report prior to the intervention and after the intervention.

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Collaborators

  • Centers for Disease Control and Prevention

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
May 28, 2015
Registry last updated
Jun 24, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.